Taking together, these data suggest a biphasic pattern of MBP regulation in AD: an early upregulation that may reflect a compensatory response to Aβ-induced myelin stress and a later decline or degradation resulting from persistent OL dysfunction, neuroinflammation, and disease progression. The gene discussed is MBP; the disease is Alzheimer disease.